Trade Mark Journal No.2025/030 25 July 2025

UK00004235454 17 July 2025 (5)

MOSEIC

International priority date claimed: 3 February 2025 (United States of America) (99027382)

Class 5: Prescription medicated and pharmaceutical preparations for the treatment and prevention of migraines; prescription medicated and pharmaceutical preparations for the treatment and prevention of neurological disorders.

Axsome Therapeutics, Inc.

Representative: Keltie LLP